Idiopathic inflammatory myopathies (IIMs) are a group of acquired diseases, characterized by immuneinflammatory processes primarily involving skeletal muscle. According to recent classification criteria, five major diseases have been identified: polymyositis (PM), dermatomyositis (DM), immune-mediated necrotizing myopathy (IMNM), juvenile idiopathic myositis (JIM) and sporadic inclusion body myositis (sIBM). Although the etiology of IIMs is still incompletely understood, there is much evidence supporting the involvement of genetic, immunological, and environmental factors. In recent years, many new biomarkers have been identified as useful indicators for diagnosis, disease subtypes, prognosis, or response to treatment of IIMs
Infantino, M., Porcelli, B., Manfredi, M. (2016). Le miopatie infiammatorie idiopatiche. In N.B. Renato Tozzoli (a cura di), Il laboratorio nelle Malattie Reumatiche Autoimmuni (pp. 407-439). Bologna : Esculapio.
Le miopatie infiammatorie idiopatiche
PORCELLI, BRUNETTA;
2016-01-01
Abstract
Idiopathic inflammatory myopathies (IIMs) are a group of acquired diseases, characterized by immuneinflammatory processes primarily involving skeletal muscle. According to recent classification criteria, five major diseases have been identified: polymyositis (PM), dermatomyositis (DM), immune-mediated necrotizing myopathy (IMNM), juvenile idiopathic myositis (JIM) and sporadic inclusion body myositis (sIBM). Although the etiology of IIMs is still incompletely understood, there is much evidence supporting the involvement of genetic, immunological, and environmental factors. In recent years, many new biomarkers have been identified as useful indicators for diagnosis, disease subtypes, prognosis, or response to treatment of IIMs
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/1007192